Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06079671 · ClinicalTrials.gov registry record · Phase 3
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
A Phase 3 study of Locally Advanced Cervical Cancer, sponsored by AstraZeneca.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 800
- Enrollment target
- 20
- Study locations
NCT06079671 is a Phase 3 study of Locally Advanced Cervical Cancer that is actively recruiting participants, run by AstraZeneca. The registered enrollment target is 800 participants. The trial reports 20 study locations across 12 states.
The verdict
NCT06079671, a Phase 3 study of Locally Advanced Cervical Cancer, is actively recruiting participants, sponsored by AstraZeneca.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 800 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a phase III, randomized, double-blind, placebo-controlled, multi-center, global study to explore the efficacy and safety of volrustomig in women with high-risk LACC (FIGO 2018 stage IIIA to IVA cervical cancer) who have not progressed following platinum-based CCRT.
Conditions Studied
Interventions
- OTHER Placebo
- BIOLOGICAL Volrustomig
Study Locations (20)
Georgia
- Research Site - Atlanta
- Research Site - Augusta
- Research Site - Savannah
Louisiana
- Research Site - New Orleans
- Research Site - New Orleans
- Research Site - Shreveport
Arizona
- Research Site - Phoenix
- Research Site - Tucson
California
- Research Site - La Jolla
- Research Site - West Hollywood
New York
- Research Site - New York
- Research Site - Syracuse
Ohio
- Research Site - Cleveland
- Research Site - Columbus
Alabama
- Research Site - Birmingham
Arkansas
- Research Site - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2023-09-22 |
| Est. Completion | 2030-09-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06079671
The ClinicalTrials.gov registry entry for NCT06079671 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Locally Advanced Cervical Cancer appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06079671 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Georgia, Louisiana, Arizona.
Frequently Asked Questions
What is clinical trial NCT06079671 about?
NCT06079671 is a clinical study titled "Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)". This is a phase III, randomized, double-blind, placebo-controlled, multi-center, global study to explore the efficacy and safety of volrustomig in women with high-risk LACC (FIGO 2018 stage IIIA to IVA cervical cancer) who have not progressed following platinum-based CCRT.
What is the current status of trial NCT06079671?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 800 participants. The study started on 2023-09-22. Estimated completion is 2030-09-30.
What conditions does trial NCT06079671 study?
This clinical trial studies the following conditions: Locally Advanced Cervical Cancer.
What interventions are being tested in trial NCT06079671?
The interventions under investigation include: Placebo (OTHER), Volrustomig (BIOLOGICAL).
Who is sponsoring clinical trial NCT06079671?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06079671 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Locally Advanced Cervical Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.